Coronavirus disease 2019 (COVID-19) has been reported to cause cardiovascular
complications such as myocardial injury, thromboembolic events, arrhythmia, and heart …

Macroautophagy/autophagy is an evolutionally conserved catabolic process in which
cytosolic contents, such as aggregated proteins, dysfunctional organelle, or invading …

Objective: This study was designed to determine the efficacy of ivermectin, an FDA-
approved drug, in producing clinical benefits and decreasing the viral load of SARS-CoV-2 …

There is increasing amount of evidence indicating the close interplays between the
replication cycle of SARS-CoV-2 and the autophagy-lysosome pathway in the host cells …

Since its emergence, the COVID-19 pandemic has been ravaging the medical and
economic sectors even with the significant vaccination advances. In severe presentations …

Background. SARS‐CoV‐2 is a new strain of the coronavirus family that emerged by the end
of 2019 and led to the unpreceded COVID‐19 pandemic. The virus affects multiple organs …

Introduction Drug repositioning is a strategy to identify a new therapeutic indication for
molecules that have been approved for other conditions, aiming to speed up the traditional …

Background: The coronavirus disease 2019 (COVID-19) is a novel coronavirus that causes
severe infection in the respiratory system. Since the immune status plays an essential role in …

During the last two years following the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic, development of potent antiviral drugs and vaccines has been a …

At the beginning of COVID-19, we underlined that this pandemic was a new challenge for
rheumatologists. On the one hand, it was necessary to clarify the impact of this new viral …